Lb Pharmaceuticals (LBRX) Amortizatization of Intangibles (2024 - 2026)
Lb Pharmaceuticals' (LBRX) quarterly Amortizatization of Intangibles came in at -$17000.0 in Q1 2026, down 241.67% year-on-year from $12000.0 in Q1 2025, and little changed quarter-over-quarter from -$17000.0 in Q4 2025.
Lb Pharmaceuticals (LBRX) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$17000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 241.67% year-over-year to -$17000.0 in Q1 2026; TTM through Mar 2026 was $39000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$261000.0, down 867.65% from the prior year.
- Amortizatization of Intangibles steadied at -$17000.0 in Q1 2026 per LBRX's latest filing, from -$17000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $61000.0 in Q4 2024 and bottomed at -$17000.0 in Q4 2025.
- The 3-year median for Amortizatization of Intangibles is -$2500.0 (2025), against an average of $9750.0.
- Across the five-year window, Amortizatization of Intangibles tumbled 127.87% in 2025 and tumbled 241.67% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $61000.0 in 2024, then tumbled by 127.87% to -$17000.0 in 2025, then changed by 0.0% to -$17000.0 in 2026.
- Per Business Quant, the three latest LBRX Amortizatization of Intangibles figures stand at -$17000.0 (Q1 2026), -$17000.0 (Q4 2025), and $12000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Lb Pharmaceuticals | 987.89 Mn | 987.89 Mn | - | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2024 | 61,000.00 |